GE HealthCare Technologies Inc. $GEHC Stock Position Boosted by ProShare Advisors LLC

ProShare Advisors LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 518,028 shares of the company’s stock after acquiring an additional 14,052 shares during the quarter. ProShare Advisors LLC’s holdings in GE HealthCare Technologies were worth $33,863,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Trian Fund Management L.P. lifted its position in shares of GE HealthCare Technologies by 76,194.4% during the second quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock worth $197,493,000 after purchasing an additional 3,081,300 shares in the last quarter. Mizuho Markets Cayman LP boosted its stake in shares of GE HealthCare Technologies by 173.2% in the first quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company’s stock valued at $218,416,000 after purchasing an additional 1,945,500 shares during the period. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of GE HealthCare Technologies by 13.2% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock valued at $861,307,000 after purchasing an additional 1,571,226 shares during the period. Amundi grew its holdings in GE HealthCare Technologies by 129.9% during the 2nd quarter. Amundi now owns 2,500,094 shares of the company’s stock valued at $160,031,000 after purchasing an additional 1,412,453 shares in the last quarter. Finally, Perpetual Ltd grew its holdings in GE HealthCare Technologies by 107.4% during the 3rd quarter. Perpetual Ltd now owns 2,712,232 shares of the company’s stock valued at $177,299,000 after purchasing an additional 1,404,683 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Strong Q3 results beat expectations. GE HealthCare reported $5.51 billion in revenue, above the $5.35 billion consensus estimate, while EPS of $1.34 exceeded expectations of $1.20. Revenue increased 7.2% year over year, helping drive the post-earnings gap higher. GE HealthCare Technologies Shares Gap Up After Strong Earnings
• Positive Sentiment: Management raised its full-year outlook. The company now expects approximately 4% organic revenue growth, adjusted EPS of $4.95–$5.05, and at least $1.6 billion in free cash flow. Organic growth of 6.2% and margin expansion in the quarter further strengthened the bullish case. GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling
• Positive Sentiment: Analysts raised valuation targets. RBC increased its target from $80 to $90 and maintained an “outperform” rating. BNP Paribas lifted its target from $96 to $100, while Mizuho raised its target from $85 to $90. BTIG Research also forecast substantial potential appreciation. BNP Paribas Price Target Update
• Neutral Sentiment: JPMorgan raised its price target from $70 to $80 but kept a “neutral” rating, suggesting recognition of the earnings improvement while retaining a cautious stance on valuation. JPMorgan GE HealthCare Rating
• Neutral Sentiment: A value comparison with Haemonetics highlights GEHC’s investment appeal but does not introduce a material new catalyst for the stock. GEHC Versus HAE Value Comparison

Analyst Ratings Changes

Several research firms recently issued reports on GEHC. Oppenheimer reaffirmed an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Bank of America reissued a “neutral” rating on shares of GE HealthCare Technologies in a research report on Thursday. Wolfe Research assumed coverage on GE HealthCare Technologies in a research note on Tuesday, October 20th. They set a “peer perform” rating for the company. Citigroup raised their target price on GE HealthCare Technologies from $71.00 to $79.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Evercore reaffirmed an “outperform” rating and set a $84.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $80.57.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $76.57 on Monday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. The stock has a market cap of $34.62 billion, a P/E ratio of 16.15, a price-to-earnings-growth ratio of 1.93 and a beta of 0.64. The stock has a 50 day moving average of $68.45 and a 200-day moving average of $70.06.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. The business had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The business’s revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.07 earnings per share. On average, analysts expect that GE HealthCare Technologies Inc. will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.16 annualized dividend and a yield of 0.2%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.38%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.